SEC Form 4 · accession 0001596783-16-000096
Catalent, Inc. · CTLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory T Lucier
Director
Period of report
Aug 24, 2016
Accepted (ET)
Aug 26, 2016 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596783
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 24, 2016 | A | 5,595 | $0.00 | A | 28,663 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package adopted in 2014. The reporting person has elected to defer 100% of such acquired equity under the amended and restated Catalent Pharma Solutions, Inc. (a wholly-owned subsidiary of the Issuer) Deferred Compensation Plan.
- F2Includes restricted stock units.